Cambridge, MA-based virtual reality workout startup VirZOOM just closed $5.5 million in seed funding, bringing the total funding to $12.2 million. The funding came from multiple investors including Skywood Capital, with personal investments from partners at Eastham Capital, Fairhaven Capital, and Equity Resource Investments, as well as the Greycroft Venture Partner Gaming Tracker Fund.
from MobiHealthNews http://ift.tt/2GDhHzN
February 01, 2018
Rose
MobiHealthNews
No comments
Related Posts:
FDA approves wearable device for opioid withdrawal symptom treatment deviceDyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withd… Read More
Medical communication tool Medici rakes in $22.4MToday medical communication startup Medici announced that it has raised $22.4 million from executives coming from Citadel, Dell, Publix, and Starwood Capital, and other unnamed investors. The Austin, Texas-based startup is ai… Read More
Studies lend credence to Click Therapeutics' digital therapeutic for depressionThe past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD). from MobiHealthNews https://ift.tt/2JVMBYW … Read More
Study: VA-sponsored telementoring improved survival rates for liver disease by 54 percentPatients of doctors who participated in a Veteran Affairs-run telemedicine consultation program were 54 percent more likely to survive chronic liver disease than a matched cohort of patients of non-participating doctors, acco… Read More
Cash incentives, wearable tracker increase steps for ischemic heart disease patientsA little bit of cash paired with a wearable activity tracker could be key in motivating people with ischemic heart disease to stay active. A recent study, published in the Journal of the American Heart Association, found that… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment